Cumberland Pharmaceuticals (CPIX) Reports Q2 EPS of $0.16

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of $0.16. Revenue for the quarter came in at $10.9 million, versus $0 reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Nomura/Instinet Starts Compeq Manufacturing (2313:TT) (SHZHY) at Buy
• United Community Banks sells equipment finance unit for $1.9 billion